Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Weiss, Glen J ^a,b   Liang, Winnie S ^b   Izatt, Tyler ^b   Arora, Shilpi ^b   Cherni, Irene ^b   Raju, Robert N ^c   Hostetter, Galen ^b   Kurdoglu, Ahmet ^b   Christoforides, Alexis ^b   Sinari, Shripad ^b   Baker, Angela S ^b   Metpally, Raghu ^b   Tembe, Waibhav D ^b   Phillips, Lori ^b   von Hoff, Daniel D ^a,b   Craig, David W ^b   Carpten, John D ^b  

^a Virginia G Piper Cancer Center   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c Innovation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CASE REPORT; CLONAL VARIATION; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; ESTHESIONEUROBLASTOMA; GENE DELETION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KDR GENE; MALE; METASTASIS POTENTIAL; MUTATIONAL ANALYSIS; NLRC4 GENE; ONCOGENE; ONCOGENE MYC; PROMOTER REGION; SIN3B GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; COPY NUMBER VARIATION; GENE LIBRARY; GENETICS; GENOME; METASTASIS; MOLECULAR GENETICS; MUTATION; NOSE CAVITY; NOSE TUMOR; NUCLEOTIDE SEQUENCE; TUMOR GENE;

ADULT; BASE SEQUENCE; DNA COPY NUMBER VARIATIONS; ESTHESIONEUROBLASTOMA, OLFACTORY; GENE LIBRARY; GENES, NEOPLASM; GENETIC VARIATION; GENOME; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NASAL CAVITY; NEOPLASM METASTASIS; NOSE NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84861414687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037029     Document Type: Article

References (38)

1. Thompson LD, (2009) Olfactory neuroblastoma. Head and neck pathology 3: 252-259.
2. Koka VN, Julieron M, Bourhis J, Janot F, Le Ridant AM, et al. (1998) Aesthesioneuroblastoma. The Journal of laryngology and otology 112: 628-633.
3. Faragalla H, Weinreb I, (2009) Olfactory neuroblastoma: a review and update. Advances in anatomic pathology 16: 322-331.
4. Zanation AM, Ferlito A, Rinaldo A, Gore MR, Lund VJ, et al. (2010) When, how and why to treat the neck in patients with esthesioneuroblastoma: a review. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies 267: 1667-1671.
5. Sohrabi S, Drabick JJ, Crist H, Goldenberg D, Sheehan JM, et al. (2011) Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 29: e358-361.
6. Mao L, Xia YP, Zhou YN, Dai RL, Yang X, et al. (2009) Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma. Oncology 77: 231-243.
7. Weinreb I, Goldstein D, Irish J, Perez-Ordonez B, (2009) Expression patterns of Trk-A, Trk-B, GRP78, and p75NRT in olfactory neuroblastoma. Human pathology 40: 1330-1335.
8. Kim JW, Kong IG, Lee CH, Kim DY, Rhee CS, et al. (2008) Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngology-head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery 139: 708-712.
9. Guled M, Myllykangas S, Frierson HF Jr, Mills SE, Knuutila S, et al. (2008) Array comparative genomic hybridization analysis of olfactory neuroblastoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 21: 770-778.
10. Koschny R, Holland H, Sykora J, Erdal H, Krupp W, et al. (2010) Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. Journal of neuro-oncology 97: 171-185.
11. Feero WG, Guttmacher AE, Collins FS, (2008) The genome gets personal-almost. JAMA: the journal of the American Medical Association 299: 1351-1352.
12. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America 104: 20007-20012.
13. Voidonikolas G, Kreml SS, Chen C, Fisher WE, Brunicardi FC, et al. (2009) Basic principles and technologies for deciphering the genetic map of cancer. World journal of surgery 33: 615-629.
14. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, et al. (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452: 872-876.
15. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
16. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
17. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
18. Korbel JO, Tirosh-Wagner T, Urban AE, Chen XN, Kasowski M, et al. (2009) The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proceedings of the National Academy of Sciences of the United States of America 106: 12031-12036.
19. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research 20: 1297-1303.
20. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. (2009) Circos: an information aesthetic for comparative genomics. Genome research 19: 1639-1645.
21. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, et al. (2002) The Bioperl toolkit: Perl modules for the life sciences. Genome research 12: 1611-1618.
22. Nibu K, Li G, Kaga K, Rothstein JL, (2000) bFGF induces differentiation and death of olfactory neuroblastoma cells. Biochemical and biophysical research communications 279: 172-180.
23. Chang HH, Lee H, Hu MK, Tsao PN, Juan HF, et al. (2010) Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 4411-4420.
24. Lahousse SA, Carter JJ, Xu XJ, Wands JR, de la Monte SM, (2006) Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells. BMC cell biology 7: 41.
25. Qiao J, Cree J, Kang J, Kim S, Evers BM, et al. (2004) Ets transcriptional regulation of gastrin-releasing peptide receptor in neuroblastomas. Surgery 136: 489-494.
26. Lee S, Das HK, (2008) Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism. Brain research 1207: 19-31.
27. Qiao J, Kang JH, Cree J, Evers BM, Chung DH, (2007) Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells. Neoplasia 9: 184-191.
28. Cho Y, Gorina S, Jeffrey PD, Pavletich NP, (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355.
29. Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, et al. (2003) Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma. Oral oncology 39: 163-169.
30. Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, et al. (1995) Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 76: 4-19.
31. Papadaki H, Kounelis S, Kapadia SB, Bakker A, Swalsky PA, et al. (1996) Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma. The American journal of surgical pathology 20: 715-721.
32. Miyagami M, Katayama Y, Kinukawa N, Sawada T, (2002) An ultrastructural and immunohistochemical study of olfactory neuroepithelioma with rhabdomyoblasts. Medical electron microscopy: official journal of the Clinical Electron Microscopy Society of Japan 35: 160-166.
33. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, et al. (1993) Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer research 53: 5284-5288.
34. Bahram F, von der Lehr N, Cetinkaya C, Larsson LG, (2000) c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95: 2104-2110.
35. Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, et al. (2009) KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors. Cancer research 69: 7175-7179.
36. Castaneda VL, Cheah MS, Saldivar VA, Richmond CM, Parmley RT, (1991) Cytogenetic and molecular evaluation of clinically aggressive esthesioneuroblastoma. The American journal of pediatric hematology/oncology 13: 62-70.
37. Dannenberg JH, David G, Zhong S, van der Torre J, Wong WH, et al. (2005) mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes & development 19: 1581-1595.
38. Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, et al. (2005) Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis. Oncogene 24: 627-636.